PharmaPrint Inc.: The Irvine developer and manufacturer...
- Share via
PharmaPrint Inc.: The Irvine developer and manufacturer of pharmaceuticals derived from herbal products recorded a loss of $1.8 million, or 16 cents a share, for its fiscal 1998 first quarter ended Sept. 30. That compares with a loss of $2.5 million, or 30 cents a share, for the year-earlier period, which included a one-time noncash stock-compensation expense charge of $1.6 million. No revenue was reported.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
